Study consists of two parts, a part 1 dose escalation and a part 2 cohort expansion in combination with dexamethasone and carfilzomib intravenously across two cohorts with a monotherapy component as well.
Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms |
No |
Study Type
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes. Searching Both is inclusive of interventional and observational studies. |
Interventional |
Eligible Ages | 18 Years and Over |
Gender | All |
Trial ID:
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries. |
NCT04973605 |
Phase
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans. Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data. Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use. |
Phase 1/Phase 2 |
Lead Sponsor
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. |
BeiGene |
Principal Investigator
The person who is responsible for the scientific and technical direction of the entire clinical study. |
N/A |
Principal Investigator Affiliation | N/A |
Agency Class
Category of organization(s) involved as sponsor (and collaborator) supporting the trial. |
Industry |
Overall Status | Recruiting |
Countries | Australia, Brazil, Canada, China, Korea, Republic of, New Zealand, United Kingdom, United States |
Conditions
The disease, disorder, syndrome, illness, or injury that is being studied. |
Relapsed/Refractory Multiple Myeloma |
Experimental: Part 1 Dose Escalation
Dose-escalation and de-escalation to determine maximum tolerated dose (MTD)
Experimental: Part 2 Cohort Expansion
There will be 5 expansion cohorts to further evaluate the safety and efficacy of BGB-11417
Drug: - BGB-11417
Administered orally daily
Drug: - Dexamethasone
Once weekly either orally or intravenously
Drug: - Carfilzomib
Administered intravenously weekly
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.
Status
Recruiting
Address
University of Alabama At Birmingham Hospital
Birmingham, Alabama, 35294
Status
Recruiting
Address
City of Hope National Medical Center
Duarte, California, 91010
Status
Recruiting
Address
City of Hope At Irvine Lennar
Irvine, California, 92618
Status
Recruiting
Address
Valkyrie Clinical Trials
Los Angeles, California, 90067
Status
Recruiting
Address
University of Miami
Miami, Florida, 33136
Status
Recruiting
Address
Tampa General Hospital
Tampa, Florida, 33606
Status
Recruiting
Address
University of Illinois Cancer Center
Chicago, Illinois, 60612
Status
Recruiting
Address
Southern Illinois University School of Medicine
Springfield, Illinois, 62629
Status
Recruiting
Address
Luminis Health Anne Arundel Medical Center
Annapolis, Maryland, 21401
Status
Recruiting
Address
Maryland Oncology Hematology, Pa
Columbia, Maryland, 21044
Status
Recruiting
Address
Massachusetts General Hospital
Boston, Massachusetts, 02114
Status
Recruiting
Address
Emory University Winship Cancer Center
Detroit, Michigan, 30322
Status
Recruiting
Address
Karmanos Cancer Institute
Detroit, Michigan, 48201
Status
Recruiting
Address
Memorial Sloan Kettering Cancer Center Mskcc
New York, New York, 10065
Status
Recruiting
Address
The James Cancer Hospital and Solove Research Institute At Ohio State University
Columbus, Ohio, 43210
Status
Recruiting
Address
Huntsman Cancer Institute
Salt Lake City, Utah, 19104
Status
Recruiting
Address
University of Washington
Seattle, Washington, 98195
Status
Recruiting
Address
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792
Status
Recruiting
Address
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Status
Recruiting
Address
Nepean Hospital
Kingswood, New South Wales, 2747
Status
Recruiting
Address
Monash Health
Clayton, Victoria, 3168
Status
Recruiting
Address
St Vincents Hospital Melbourne
Fitzroy, Victoria, 3065
Status
Recruiting
Address
The Alfred Hospital
Melbourne, Victoria, 3004
Status
Recruiting
Address
Royal Perth Hospital
Perth, Western Australia, 6000
Status
Recruiting
Address
Hospital Sirio Libanes Brasilia
Brasilia, , 70200-730
Status
Recruiting
Address
Instituto Dor de Pesquisa E Ensino Distrito Federal
Brasilia, , 70390140
Status
Recruiting
Address
Centro Gaucho Integrado de Oncologia Hospital Mae de Deus
Porto Alegre, , 90850-170
Status
Recruiting
Address
Instituto Dor de Pesquisa E Ensino Sao Paulo
Sao Paulo, , 01401-002
Status
Recruiting
Address
Hospital Nove de Julho Dasa
Sao Paulo, , 01409-902
Status
Recruiting
Address
Accamargo Cancer Center
Sao Paulo, , 01508-010
Status
Recruiting
Address
Clinica Sao Germano
Sao Paulo, , 04537-080
Status
Recruiting
Address
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
Sao Paulo, , 05653-120
Status
Recruiting
Address
Cross Cancer Institute
Edmonton, Alberta, T6G1Z2
Status
Recruiting
Address
British Columbia Cancer Agency the Vancouver Centre
Vancouver, British Columbia, V5Z 4E6
Status
Recruiting
Address
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C9
Status
Recruiting
Address
Jewish General Hospital
Montreal, Quebec, QC H3t 1E2
Status
Recruiting
Address
Beijing Chao Yang Hospital
Beijing, Beijing, 100020
Status
Recruiting
Address
Peking University Peoples Hospital
Beijing, Beijing, 100044
Status
Recruiting
Address
Chongqing Cancer Hospital
Chongqing, Chongqing, 400030
Status
Recruiting
Address
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001
Status
Recruiting
Address
Sun Yat Sen University Cancer Center
Guangzhou, Guangdong, 510060
Status
Recruiting
Address
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000
Status
Recruiting
Address
Henan Cancer Hospital
Zhengzhou, Henan, 450000
Status
Recruiting
Address
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052
Status
Recruiting
Address
Hunan Cancer Hospital
Changsha, Hunan, 410013
Status
Recruiting
Address
The First Affiliated Hospital of Nanchang University Branch Xianghu
Nanchang, Jiangxi, 332000
Status
Recruiting
Address
The First Hospital of China Medical University
Shenyang, Liaoning, 110001
Status
Recruiting
Address
Qingdao Municipal Hospital
Qingdao, Shandong, 266000
Status
Recruiting
Address
Affiliated Zhongshan Hospital of Fudan University
Shanghai, Shanghai, 200032
Status
Recruiting
Address
Shanghai Fourth Peoples Hospital Affiliated to Tongji University
Shanghai, Shanghai, 200434
Status
Recruiting
Address
Tianjin Medical University General Hospital
Tianjin, Tianjin, 300052
Status
Recruiting
Address
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003
Status
Recruiting
Address
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi, 03080
Status
Recruiting
Address
Severance Hospital Yonsei University Health System
Seoul, Seoul Teugbyeolsi, 03722
Status
Recruiting
Address
Asan Medical Center
Seoul, Seoul Teugbyeolsi, 05505
Status
Recruiting
Address
Samsung Medical Center
Seoul, Seoul Teugbyeolsi, 06351
Status
Recruiting
Address
The Catholic University of Korea, Seoul St Marys Hospital
Seoul, Seoul Teugbyeolsi, 06591
Status
Recruiting
Address
Aotearoa Clinical Trials
Auckland, , 2025
Status
Recruiting
Address
University College Hospital
London, , NW1 2PG
Status
Recruiting
Address
Royal Marsden Nhs Foundation Royal Marsden Hospital
Sutton, , SM2 5PT
Status
Recruiting
Address
Royal Cornwall Hospitalsnhs Trust
Truro, , TR1 3LJ